Filoviruses: Innate Immunity, Inflammatory Cell Death, and Cytokines.

Jianlin Lu, Jessica M Gullett, Thirumala-Devi Kanneganti
Author Information
  1. Jianlin Lu: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  2. Jessica M Gullett: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. ORCID
  3. Thirumala-Devi Kanneganti: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. ORCID

Abstract

Filoviruses are a group of single-stranded negative sense RNA viruses. The most well-known filoviruses that affect humans are ebolaviruses and marburgviruses. During infection, they can cause life-threatening symptoms such as inflammation, tissue damage, and hemorrhagic fever, with case fatality rates as high as 90%. The innate immune system is the first line of defense against pathogenic insults such as filoviruses. Pattern recognition receptors (PRRs), including toll-like receptors, retinoic acid-inducible gene-I-like receptors, C-type lectin receptors, AIM2-like receptors, and NOD-like receptors, detect pathogens and activate downstream signaling to induce the production of proinflammatory cytokines and interferons, alert the surrounding cells to the threat, and clear infected and damaged cells through innate immune cell death. However, filoviruses can modulate the host inflammatory response and innate immune cell death, causing an aberrant immune reaction. Here, we discuss how the innate immune system senses invading filoviruses and how these deadly pathogens interfere with the immune response. Furthermore, we highlight the experimental difficulties of studying filoviruses as well as the current state of filovirus-targeting therapeutics.

Keywords

References

  1. J Virol. 2004 Nov;78(21):12090-5 [PMID: 15479853]
  2. JCI Insight. 2019 Jan 10;4(1): [PMID: 30626757]
  3. J Virol. 2007 Dec;81(24):13469-77 [PMID: 17928350]
  4. Sci Transl Med. 2017 Apr 5;9(384): [PMID: 28381540]
  5. Vaccine. 2007 Mar 1;25(11):1923-34 [PMID: 17241710]
  6. Cell Microbiol. 2007 Apr;9(4):962-76 [PMID: 17381429]
  7. Trends Microbiol. 2001 Mar;9(3):113-4 [PMID: 11303500]
  8. J Infect Dis. 1999 Feb;179 Suppl 1:S199-202 [PMID: 9988185]
  9. J Interferon Cytokine Res. 2014 Feb;34(2):79-89 [PMID: 24102579]
  10. Nat Med. 2021 Oct;27(10):1674-1675 [PMID: 34480126]
  11. Curr Top Microbiol Immunol. 2017;411:293-322 [PMID: 28685291]
  12. Cells. 2022 Apr 29;11(9): [PMID: 35563804]
  13. Cell Death Differ. 2017 Jul;24(7):1184-1195 [PMID: 28498367]
  14. PLoS Pathog. 2015 Apr 30;11(4):e1004731 [PMID: 25928849]
  15. Nature. 2019 Oct;574(7778):428-431 [PMID: 31511692]
  16. Front Immunol. 2022 Jan 05;12:694105 [PMID: 35069519]
  17. J Immunol. 2007 May 15;178(10):6444-55 [PMID: 17475874]
  18. Nature. 2011 Aug 24;477(7364):340-3 [PMID: 21866103]
  19. Proc Natl Acad Sci U S A. 2011 May 17;108(20):8426-31 [PMID: 21536871]
  20. Nature. 2021 Sep;597(7876):415-419 [PMID: 34471287]
  21. Cell Rep. 2016 Feb 23;14(7):1632-1640 [PMID: 26876165]
  22. Aging (Albany NY). 2020 Jun 19;12(12):11163-11164 [PMID: 32575071]
  23. Viruses. 2017 Mar 22;9(3): [PMID: 28327518]
  24. Nature. 2006 Mar 9;440(7081):237-41 [PMID: 16407889]
  25. Naturwissenschaften. 1999 Jan;86(1):8-17 [PMID: 10024977]
  26. J Virol. 2009 Apr;83(7):2883-91 [PMID: 19144707]
  27. J Biol Chem. 2008 Jun 6;283(23):15825-33 [PMID: 18411269]
  28. Front Cell Infect Microbiol. 2020 May 29;10:237 [PMID: 32547960]
  29. Nature. 2009 Mar 26;458(7237):509-13 [PMID: 19158676]
  30. Comput Struct Biotechnol J. 2021 Aug 03;19:4641-4657 [PMID: 34504660]
  31. Curr Opin Immunol. 2020 Feb;62:39-44 [PMID: 31837596]
  32. Nat Rev Microbiol. 2015 Nov;13(11):663-76 [PMID: 26439085]
  33. PLoS Pathog. 2010 Sep 23;6(9):e1001121 [PMID: 20886108]
  34. Cell Rep. 2021 Oct 19;37(3):109858 [PMID: 34686350]
  35. J Interferon Cytokine Res. 2009 Sep;29(9):511-20 [PMID: 19694547]
  36. Nat Rev Immunol. 2007 May;7(5):353-64 [PMID: 17457343]
  37. J Virol. 2017 May 12;91(11): [PMID: 28331091]
  38. J Exp Med. 2004 Jul 19;200(2):169-79 [PMID: 15249592]
  39. Cell. 1997 Nov 14;91(4):479-89 [PMID: 9390557]
  40. Virology. 2017 Jan 15;501:147-165 [PMID: 27930961]
  41. J Virol. 2004 Mar;78(6):2943-7 [PMID: 14990712]
  42. mBio. 2017 Sep 26;8(5): [PMID: 28951472]
  43. J Virol. 2003 Jan;77(2):1337-46 [PMID: 12502850]
  44. Cell. 1998 Aug 21;94(4):481-90 [PMID: 9727491]
  45. Cell Mol Immunol. 2021 May;18(5):1106-1121 [PMID: 33785842]
  46. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7 [PMID: 17190814]
  47. Front Immunol. 2014 Sep 25;5:461 [PMID: 25309543]
  48. Nature. 2006 Mar 9;440(7081):233-6 [PMID: 16407888]
  49. PLoS Negl Trop Dis. 2020 Sep 4;14(9):e0008602 [PMID: 32886656]
  50. PLoS Pathog. 2014 Nov 20;10(11):e1004509 [PMID: 25412102]
  51. Cell. 2020 Mar 19;180(6):1044-1066 [PMID: 32164908]
  52. Nat Commun. 2021 Mar 25;12(1):1891 [PMID: 33767178]
  53. Nat Immunol. 2015 Aug;16(8):802-9 [PMID: 26194286]
  54. J Infect Dis. 2007 Nov 15;196 Suppl 2:S237-46 [PMID: 17940955]
  55. Nature. 2006 Mar 9;440(7081):228-32 [PMID: 16407890]
  56. Cell Host Microbe. 2013 Jul 17;14(1):74-84 [PMID: 23870315]
  57. Viruses. 2019 Mar 19;11(3): [PMID: 30893774]
  58. Front Microbiol. 2013 Sep 05;4:267 [PMID: 24046765]
  59. J Infect Dis. 1999 Feb;179 Suppl 1:S188-91 [PMID: 9988183]
  60. Lancet Infect Dis. 2022 Jan;22(1):97-109 [PMID: 34529963]
  61. Clin Exp Immunol. 2002 Apr;128(1):163-8 [PMID: 11982604]
  62. BMJ. 2014 Dec 10;349:g7348 [PMID: 25497512]
  63. J Virol. 2010 Jan;84(1):27-33 [PMID: 19846529]
  64. J Immunol. 2005 Sep 1;175(5):2851-8 [PMID: 16116171]
  65. Nature. 2016 Jul 06;535(7610):153-8 [PMID: 27383986]
  66. Cell. 2010 May 14;141(4):668-81 [PMID: 20451243]
  67. J Biol Chem. 1999 Jan 8;274(2):1156-63 [PMID: 9873064]
  68. Front Cell Infect Microbiol. 2020 Jun 03;10:238 [PMID: 32582562]
  69. J Virol. 2010 Jan;84(1):163-75 [PMID: 19846533]
  70. J Infect Dis. 2018 Nov 22;218(suppl_5):S496-S503 [PMID: 30101349]
  71. Nat Med. 1999 Apr;5(4):423-6 [PMID: 10202932]
  72. Curr Med Chem. 2009;16(24):3152-67 [PMID: 19689289]
  73. Clin Infect Dis. 2016 Aug 15;63(4):460-7 [PMID: 27353663]
  74. J Virol. 2006 Apr;80(8):4174-8 [PMID: 16571833]
  75. Virology. 2000 Dec 5;278(1):20-6 [PMID: 11112476]
  76. Cell Host Microbe. 2014 Aug 13;16(2):187-200 [PMID: 25121748]
  77. PLoS Pathog. 2021 Dec 9;17(12):e1010078 [PMID: 34882741]
  78. Biomed Res Int. 2021 Sep 12;2021:1157023 [PMID: 34552981]
  79. Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13237-42 [PMID: 26464513]
  80. Science. 2005 Jun 10;308(5728):1643-5 [PMID: 15831716]
  81. N Engl J Med. 2019 Dec 12;381(24):2293-2303 [PMID: 31774950]
  82. J Immunol. 2009 May 1;182(9):5682-92 [PMID: 19380815]
  83. Genes Dev. 2000 Aug 15;14(16):2060-71 [PMID: 10950869]
  84. J Gen Virol. 1995 Feb;76 ( Pt 2):393-9 [PMID: 7844558]
  85. Trends Immunol. 2013 Feb;34(2):67-73 [PMID: 23122052]
  86. PLoS Pathog. 2008 Aug 29;4(8):e1000141 [PMID: 18769720]
  87. Trends Immunol. 2017 Jan;38(1):39-52 [PMID: 27863906]
  88. N Engl J Med. 2017 Mar 9;376(10):928-938 [PMID: 25426834]
  89. Cell. 2002 Nov 1;111(3):331-42 [PMID: 12419244]
  90. J Virol. 2001 Nov;75(22):11025-33 [PMID: 11602743]
  91. J Virol. 2006 Jun;80(11):5156-67 [PMID: 16698996]
  92. Hum Vaccin. 2011 Jun;7(6):701-11 [PMID: 21519188]
  93. Front Cell Infect Microbiol. 2020 Jul 07;10:309 [PMID: 32733813]
  94. Trends Immunol. 2021 Aug;42(8):681-705 [PMID: 34217595]
  95. J Virol. 2006 Oct;80(20):10109-16 [PMID: 17005688]
  96. Nature. 2009 Mar 26;458(7237):514-8 [PMID: 19158675]
  97. Cell. 2020 Apr 30;181(3):674-687.e13 [PMID: 32298652]
  98. Mitochondrion. 2010 Jun;10(4):316-20 [PMID: 20206303]
  99. Cell Res. 2015 Dec;25(12):1285-98 [PMID: 26611636]
  100. Oncogene. 2004 Mar 4;23(9):1789-800 [PMID: 14676839]
  101. J Virol. 2010 Mar;84(6):3004-15 [PMID: 20071589]
  102. Immunity. 2019 Apr 16;50(4):907-923 [PMID: 30995506]
  103. J Immunol. 2022 Sep 1;209(5):845-854 [PMID: 36130131]
  104. Clin Vaccine Immunol. 2013 Mar;20(3):319-27 [PMID: 23283640]
  105. Lab Invest. 2000 Feb;80(2):171-86 [PMID: 10701687]
  106. Cell. 2001 Jul 13;106(1):117-26 [PMID: 11461707]
  107. Virology (Auckl). 2019 Jun 21;10:1178122X19849927 [PMID: 31258326]
  108. PLoS Negl Trop Dis. 2010 Oct 05;4(10): [PMID: 20957152]
  109. Nat Rev Immunol. 2007 Jul;7(7):556-67 [PMID: 17589545]
  110. J Immunol. 2010 Jan 1;184(1):327-35 [PMID: 20028660]
  111. Nature. 2015 Oct 29;526(7575):666-71 [PMID: 26375259]
  112. Nat Rev Microbiol. 2019 Oct;17(10):593-606 [PMID: 31341272]
  113. Cancers (Basel). 2021 Jan 26;13(3): [PMID: 33530653]
  114. Arch Virol. 2010 Dec;155(12):2083-103 [PMID: 21046175]
  115. Virol J. 2019 Dec 30;16(1):165 [PMID: 31888676]
  116. Sci Rep. 2015 May 26;5:9912 [PMID: 26011078]
  117. J Immunol. 2005 Oct 15;175(8):5260-8 [PMID: 16210631]
  118. Cell Death Differ. 2007 Jan;14(1):56-65 [PMID: 16977332]
  119. Immunol Rev. 2020 Sep;297(1):5-12 [PMID: 32856334]
  120. Cell. 2012 Jan 20;148(1-2):213-27 [PMID: 22265413]
  121. Lancet Infect Dis. 2017 Aug;17(8):854-866 [PMID: 28606591]
  122. Mol Cell. 2002 Aug;10(2):417-26 [PMID: 12191486]
  123. Nat Rev Immunol. 2005 May;5(5):375-86 [PMID: 15864272]
  124. Nat Immunol. 2006 Jun;7(6):569-75 [PMID: 16648853]
  125. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1512-7 [PMID: 20080593]
  126. Virology. 2003 Jan 5;305(1):115-23 [PMID: 12504546]
  127. J Virol. 2007 Dec;81(24):13378-84 [PMID: 17928356]
  128. Cell. 2014 Mar 13;156(6):1193-1206 [PMID: 24630722]
  129. PLoS Pathog. 2022 May 9;18(5):e1010530 [PMID: 35533151]
  130. J Am Vet Med Assoc. 2009 May 1;234(9):1130-9 [PMID: 19405883]
  131. Signal Transduct Target Ther. 2021 Aug 4;6(1):291 [PMID: 34344870]
  132. Br J Cancer. 1972 Aug;26(4):239-57 [PMID: 4561027]
  133. Curr Top Microbiol Immunol. 2017;411:3-21 [PMID: 28766193]
  134. J Virol. 2003 Jul;77(13):7539-44 [PMID: 12805454]
  135. Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7858-63 [PMID: 27339137]
  136. Nature. 2015 Oct 29;526(7575):660-5 [PMID: 26375003]
  137. Med Sci (Paris). 2018 Aug-Sep;34(8-9):671-677 [PMID: 30230452]
  138. Nature. 2016 Jul 7;535(7610):111-6 [PMID: 27281216]
  139. EBioMedicine. 2015 Nov 27;3:67-78 [PMID: 26870818]
  140. Am J Pathol. 2003 Dec;163(6):2347-70 [PMID: 14633608]
  141. Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20661-6 [PMID: 23185024]
  142. EMBO J. 2016 Aug 15;35(16):1766-78 [PMID: 27418190]
  143. J Intern Med. 2010 May;267(5):473-82 [PMID: 20433575]
  144. Cell. 1996 Jun 14;85(6):803-15 [PMID: 8681376]
  145. Front Cell Infect Microbiol. 2019 Nov 26;9:406 [PMID: 31850239]
  146. J Virol. 2019 May 1;93(10): [PMID: 30814283]
  147. Virology. 2017 Sep;509:23-34 [PMID: 28595092]
  148. Nature. 2006 May 4;441(7089):101-5 [PMID: 16625202]
  149. Cell. 1996 Jun 14;85(6):817-27 [PMID: 8681377]
  150. Nat Rev Drug Discov. 2018 Jun;17(6):413-434 [PMID: 29375139]
  151. Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5322-7 [PMID: 22421439]
  152. Curr Top Microbiol Immunol. 2017;411:323-352 [PMID: 28601947]
  153. Nat Immunol. 2006 Jun;7(6):576-82 [PMID: 16648852]
  154. Genome Biol. 2007;8(8):R174 [PMID: 17725815]
  155. Nature. 2014 Sep 11;513(7517):237-41 [PMID: 24919149]
  156. Annu Rev Immunol. 2020 Apr 26;38:567-595 [PMID: 32017655]
  157. J Virol. 2013 May;87(10):5384-96 [PMID: 23468487]
  158. Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17545-50 [PMID: 16251271]
  159. Cell. 2021 Jan 7;184(1):149-168.e17 [PMID: 33278357]
  160. J Virol. 2017 Mar 29;91(8): [PMID: 28122983]
  161. J Infect Dis. 2018 Nov 22;218(suppl_5):S504-S507 [PMID: 30060221]
  162. mBio. 2017 Apr 25;8(2): [PMID: 28442605]
  163. Br J Pharmacol. 2014 Dec;171(24):5589-602 [PMID: 25117218]
  164. J Infect Dis. 2011 Nov;204 Suppl 3:S957-67 [PMID: 21987776]
  165. Cell Host Microbe. 2010 Jul 22;8(1):44-54 [PMID: 20638641]
  166. PLoS Pathog. 2010 Jan 15;6(1):e1000721 [PMID: 20084112]
  167. Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14 [PMID: 20823910]
  168. Cell. 1998 Aug 21;94(4):491-501 [PMID: 9727492]
  169. Front Microbiol. 2021 Jul 30;12:713372 [PMID: 34394063]
  170. Front Immunol. 2021 May 18;12:609543 [PMID: 34093517]
  171. Arch Biochem Biophys. 2019 Jul 30;670:4-14 [PMID: 30772258]
  172. Annu Rev Immunol. 2009;27:519-50 [PMID: 19302047]
  173. Cell. 2014 Mar 13;156(6):1207-1222 [PMID: 24630723]
  174. J Virol. 2002 Jul;76(13):6841-4 [PMID: 12050398]
  175. Nat Rev Immunol. 2020 Sep;20(9):537-551 [PMID: 32203325]
  176. Blood Rev. 2017 Sep;31(5):306-317 [PMID: 28495184]

Grants

  1. R35 CA253095/NCI NIH HHS
  2. AI101935/NIH HHS
  3. R01 AI101935/NIAID NIH HHS
  4. R01 AI124346/NIAID NIH HHS
  5. R37 AI101935/NIAID NIH HHS
  6. R01 AI160179/NIAID NIH HHS
  7. AR056296/NIH HHS
  8. AI124346/NIH HHS
  9. R01 AR056296/NIAMS NIH HHS
  10. CA253095/NIH HHS
  11. AI160179/NIH HHS

Word Cloud

Created with Highcharts 10.0.0receptorsimmunefilovirusesinnatecelldeathRNAcaninflammationsystemrecognitionpathogenscellsresponseFilovirusesgroupsingle-strandednegativesenseviruseswell-knownaffecthumansebolavirusesmarburgvirusesinfectioncauselife-threateningsymptomstissuedamagehemorrhagicfevercasefatalityrateshigh90%firstlinedefensepathogenicinsultsPatternPRRsincludingtoll-likeretinoicacid-induciblegene-I-likeC-typelectinAIM2-likeNOD-likedetectactivatedownstreamsignalinginduceproductionproinflammatorycytokinesinterferonsalertsurroundingthreatclearinfecteddamagedHowevermodulatehostinflammatorycausingaberrantreactiondiscusssensesinvadingdeadlyinterfereFurthermorehighlightexperimentaldifficultiesstudyingwellcurrentstatefilovirus-targetingtherapeuticsFiloviruses:InnateImmunityInflammatoryCellDeathCytokinesALRsCLRsNLRsPANoptosisPANoptosomeRIG-IRLRsvirusTLRsapoptosiscaspaseebolavirusfilovirushost���pathogeninteractionsinflammasomeimmunityinterferonmarburgvirusnecroptosispatternpyroptosis

Similar Articles

Cited By